Granstein R D, Flotte T J, Amento E P
Wellman Laboratories of Photomedicine, Department of Dermatology, Massachusetts General Hospital, Boston 02114.
J Invest Dermatol. 1990 Dec;95(6 Suppl):75S-80S. doi: 10.1111/1523-1747.ep12874789.
The immunoregulatory, antiviral, and antiproliferative agents known as the interferons have profound effects on collagen synthesis. Interferons alpha, beta, and gamma suppress collagen synthesis by dermal fibroblasts. In addition, interferon gamma (IFN-gamma) inhibits the constitutively increased collagen synthesis characteristic of fibroblasts derived from lesions of patients with scleroderma. IFN-gamma also inhibits collagen synthesis by myofibroblasts and synovial fibroblast-like cells. Inhibition of collagen synthesis by IFN-gamma is associated with a coordinate inhibition of transcription for types I and III collagen. In addition, IFN-gamma suppresses levels of procollagen mRNA and type II collagen synthesis in human articular chondrocytes. In vivo studies in mice have demonstrated that IFN-gamma inhibits the collagen synthesis associated with the fibrotic response to an implanted foreign body, bleomycin-induced pulmonary fibrosis, and the healing response to cutaneous thermal burns. In the latter case, while collagen content of the wound scar was decreased, hyaluronic acid was increased in mice receiving IFN-gamma compared to controls. This is in accord with in vitro studies showing that, while interferons alpha and beta decrease production of glycosaminoglycans, IFN-gamma increases production of glycosaminoglycans. Of interest, acute inflammation at sites of thermal injury, or when elicited by proinflammatory agents in separate experiments, also was suppressed in mice treated with IFN-gamma. The means by which IFN-gamma inhibits collagen synthesis involves transcriptional regulation. There is a single report that interferon alpha can decrease the size of a keloid of recent onset in a human patient. Because the interferons can inhibit collagen synthesis in vivo, further studies may be warranted to evaluate the usefulness of these agents in the treatment of disease states characterized by abnormal fibrotic responses as well as their potential for altering the healing response associated with particular therapeutic interventions.
被称为干扰素的免疫调节、抗病毒和抗增殖剂对胶原蛋白合成有深远影响。α、β和γ干扰素可抑制真皮成纤维细胞的胶原蛋白合成。此外,γ干扰素(IFN-γ)可抑制硬皮病患者病损处成纤维细胞特有的持续性胶原蛋白合成增加。IFN-γ还可抑制肌成纤维细胞和滑膜成纤维样细胞的胶原蛋白合成。IFN-γ对胶原蛋白合成的抑制与I型和III型胶原蛋白转录的协同抑制有关。此外,IFN-γ可抑制人关节软骨细胞中前胶原蛋白mRNA水平和II型胶原蛋白合成。在小鼠体内的研究表明,IFN-γ可抑制与植入异物的纤维化反应、博来霉素诱导的肺纤维化以及皮肤热烧伤愈合反应相关的胶原蛋白合成。在后一种情况下,与对照组相比,接受IFN-γ的小鼠伤口瘢痕中的胶原蛋白含量降低,而透明质酸增加。这与体外研究结果一致,即α和β干扰素可降低糖胺聚糖的产生,而IFN-γ可增加糖胺聚糖的产生。有趣的是,在用IFN-γ治疗的小鼠中,热损伤部位的急性炎症,或在单独实验中由促炎剂引发的急性炎症也受到抑制。IFN-γ抑制胶原蛋白合成的方式涉及转录调控。有一份报告称,α干扰素可减小一名人类患者近期出现的瘢痕疙瘩的大小。由于干扰素可在体内抑制胶原蛋白合成,因此可能有必要进行进一步研究,以评估这些药物在治疗以异常纤维化反应为特征的疾病状态中的有用性,以及它们改变与特定治疗干预相关的愈合反应的潜力。